PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075926
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075926
Europe Gelatin And Bone Glue Market is estimated to be valued at USD 289.7 Mn in 2026 and is expected to reach USD 444.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 289.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.30% | 2033 Value Projection: | USD 444.3 Mn |
Gelatin is obtained from collagen, which present in the ligaments, tendons, and tissues of mammals. Gelatin is used as bone void fillers, hemostatic sponges, and biodegradable orthopedic implants. There are two types of bone glues used synthetic and natural bone glues respectively. Increasing number of joint replacement procedures is expected to propel growth of Europe gelatin and bone glue market over the forecast period. Furthermore, increasing cases of sports-related injuries is expected is also anticipated to assist the growth of the market during the forecast period.
The gelatin and bone glue market is driven by demand from pharmaceuticals, food and beverages, healthcare, and cosmetics. Gelatin and bone glue offer versatile applications in these industries, including its use in pharmaceutical formulations, surgical adhesives, and collagen-rich products. However, challenges arise from the emergence of plant-based alternatives and the need for compliance with stringent regulations. Nonetheless, the market continues to thrive due to the inherent properties and benefits of gelatin and bone glue, making them indispensable in various sectors.
On March 13, 2023, a UCLA-led research team introduced a biodegradable hydrogel adhesive inspired by mussels, offering a strong and precise solution for sealing surgical wounds. The adhesive, injected from a syringe, demonstrated three times the strength of comparable bioglues and exhibited a honey-like viscosity for effective sealing of curved and wet tissues. Taking cues from mussels' ability to adhere to wet surfaces, the team modified gelatin with catechols, enhancing its adhesive properties.
On November 26, 2022, RevBio, Inc. initiated an experiment onboard the International Space Station (ISS) to study TETRANITE, a regenerative bone adhesive biomaterial. The research aims to assess TETRANITE's ability to regenerate bone under microgravity conditions simulating osteoporosis. The study materials were launched as part of SpaceX's 26th Commercial Resupply Services mission.